Social Capital Suvretta Holdings Corp IV Cl A (DNAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNAD | AZN | AMGN | GILD | VRTX |
| Company | Social Capital Suvretta Holdings Corp IV Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.35 | 173.45 | 367.82 | 135.57 | 495.58 |
| High | 10.36 | 180.21 | 368.75 | 136.06 | 500.77 |
| Low | 10.34 | 172.76 | 361.61 | 133.27 | 482.11 |
| Latest | 10.35 | 178.49 | 362.82 | 133.64 | 486.81 |
| Change | +0.01 | -10.79 | -5.17 | -2.18 | -11.62 |
| % Change | +0.10% | -5.70% | -1.40% | -1.61% | -2.33% |
| Volume | 144,200 | 4,710,967 | 550,243 | 2,189,020 | 802,658 |
| 20-Day Average Volume | 127,825 | 2,134,626 | 2,983,888 | 8,640,425 | 1,985,225 |
| Previous Close | 10.34 | 189.28 | 367.99 | 135.82 | 498.43 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.33 | 183.78 | 355.10 | 127.29 | 479.09 |
| 20-Day Raw Stochastic | 83.33% | 28.68% | 68.86% | 74.46% | 53.51% |
| 20-Day Relative Strength | 65.52 | 45.91 | 56.92 | 55.11 | 55.99 |
| Weighted Alpha | +6.50 | +17.27 | +22.32 | +17.76 | +10.62 |
| Today's Opinion | 100% Buy | 72% Sell | 72% Buy | 24% Sell | 72% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 72% Buy | 8% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 40% Sell | 24% Buy | 40% Sell | Hold |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 06/23/23 | -2.09% since 07/01/26 | +0.30% since 07/01/26 | +6.01% since 07/01/26 | -2.16% since 07/01/26 |
| Low | 10.33 on 06/28/23 | 173.43 on 07/09/26 | 359.47 on 07/06/26 | 126.46 on 07/02/26 | 482.11 on 07/09/26 |
| High | 10.36 on 06/30/23 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 533.67 on 07/07/26 |
| 1-Month | |||||
| %Chg | +0.38% since 05/30/23 | -1.86% since 06/09/26 | +5.18% since 06/09/26 | +6.40% since 06/09/26 | +9.30% since 06/09/26 |
| Low | 10.30 on 06/01/23 | 173.43 on 07/09/26 | 334.05 on 06/18/26 | 121.39 on 06/10/26 | 433.80 on 06/10/26 |
| High | 10.36 on 06/30/23 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 533.67 on 07/07/26 |
| 3-Month | |||||
| %Chg | +1.27% since 03/30/23 | -12.18% since 04/09/26 | +1.92% since 04/09/26 | -6.02% since 04/09/26 | +9.06% since 04/09/26 |
| Low | 10.22 on 04/10/23 | 173.43 on 07/09/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 10.46 on 04/12/23 | 207.30 on 04/10/26 | 375.25 on 07/07/26 | 142.38 on 04/10/26 | 533.67 on 07/07/26 |
| 6-Month | |||||
| %Chg | +2.99% since 12/30/22 | -4.90% since 01/09/26 | +11.14% since 01/09/26 | +10.27% since 01/09/26 | +5.04% since 01/09/26 |
| Low | 10.04 on 01/04/23 | 173.43 on 07/09/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 412.27 on 05/05/26 |
| High | 10.92 on 01/12/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 533.67 on 07/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 330,061 | 293,555,872 | 198,607,136 | 168,630,048 | 126,504,016 |
| Shares Outstanding, K | 31,890 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 2,740,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | 2,460,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.01 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/15/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 01/01/70 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.86 | 16.66 | 16.29 | 31.05 |